[{"_1":2,"_445":-5,"_446":-5},"loaderData",{"_3":4,"_13":14},"root",{"_5":6,"_7":8,"_9":10,"_11":12},"theme",0,"baseURL","https://pocketcasts.com","locale","en","region","global","routes/_app.podcast.$podcastSlug.$podcastUuid.$episodeSlug.$episodeUuid",{"_15":16,"_17":18,"_19":20},"podcastUuid","0d324d20-779a-0138-ede8-0acc26574db2","episodeUuid","9f51ee83-b790-4fec-b063-08ed03d97b43","dehydratedState",{"_21":22,"_23":24},"mutations",[],"queries",[25,438],{"_26":27,"_28":29,"_432":433,"_436":437},"dehydratedAt",1775301111312,"state",{"_30":31,"_418":419,"_420":27,"_421":-5,"_422":6,"_423":6,"_424":6,"_425":-5,"_426":-5,"_427":55,"_428":429,"_430":431},"data",{"_32":33,"_34":35,"_36":37,"_38":39,"_40":41,"_42":41,"_43":44,"_45":46,"_47":48,"_49":16,"_50":51,"_52":53,"_54":55,"_56":46,"_57":58,"_410":411,"_412":413,"_414":415,"_416":55,"_417":6},"url","https://jamanetwork.com/journals/jama/pages/jamaevidence-jama-guide-to-statistics-and-methods","title","JAMAevidence JAMA Guide to Statistics and Methods","slug","jamaevidence-jama-guide-to-statistics-and-methods","author","JAMA Network","description","Interviews with authors of JAMA Guide to Statistics and Methods chapters about common and new statistics and methods used in clinical research and reported in medical journals.","description_html","category","Health & Fitness\n Medicine\nScience","audio",true,"show_type","episodic","uuid","fundings",[],"guid","","is_private",false,"transcript_eligible","episodes",[59,74,82,90,98,106,114,122,130,138,146,154,162,170,178,186,194,202,210,218,226,234,242,250,258,266,274,282,290,298,306,314,322,330,338,346,354,362,370,378,386,394,402],{"_49":18,"_34":60,"_36":61,"_32":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":46,"_15":16},"Test-Negative Study Designs for Evaluating Vaccine Effectiveness With Dr Dean","test-negative-study-designs-for-evaluating-vaccine-effectiveness-with-dr-dean","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Test-Negative_Study_Designs_for_Evaluating_Vaccine_Effectiveness_With_Dr_Dean_1.mp3?dest-id=1862984","file_type","audio/mpeg","file_size",32273918,"duration",805,"published","2026-04-02T15:00:00Z","type","full","has_generated_transcript",{"_49":75,"_34":76,"_36":77,"_32":78,"_63":64,"_65":79,"_67":80,"_69":81,"_71":72,"_73":46,"_15":16},"2dc26e71-8214-4002-a2d5-205c04ffb1f9","Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments With Dr Webb","platform-clinical-trials-for-the-efficient-evaluation-of-multiple-treatments-with-dr-webb","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Platform_Clinical_Trials_for_the_Efficient_Evaluation_of_Multiple_Treatments_With_Dr_Webb_1.mp3?dest-id=1862984",41559877,1037,"2026-03-05T16:00:00Z",{"_49":83,"_34":84,"_36":85,"_32":86,"_63":64,"_65":87,"_67":88,"_69":89,"_71":72,"_73":46,"_15":16},"262dd066-28f9-4001-bddc-793d2e2c390d","Tipping Point Analysis: Assessing the Potential Impact of Missing Data With Dr Sims","tipping-point-analysis-assessing-the-potential-impact-of-missing-data-with-dr-sims","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Tipping_Point_Analysis_Assessing_the_Potential_Impact_of_Missing_Data_With_Dr_Sims.mp3?dest-id=1862984",24101945,601,"2026-01-08T16:00:00Z",{"_49":91,"_34":92,"_36":93,"_32":94,"_63":64,"_65":95,"_67":96,"_69":97,"_71":72,"_73":46,"_15":16},"d82fa25c-73b3-4a28-8427-b4c95b93e378","Instrumental Variables and Heterogeneous Treatment Effects With Dr Norton","instrumental-variables-and-heterogeneous-treatment-effects-with-dr-norton","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/University_of_Michigan_Health_Management_and_Policy_With__Dr_Norton.mp3?dest-id=1862984",44182628,1103,"2025-09-04T15:00:00Z",{"_49":99,"_34":100,"_36":101,"_32":102,"_63":64,"_65":103,"_67":104,"_69":105,"_71":72,"_73":55,"_15":16},"153652b3-b08a-43b3-9999-1d6665650485","Factorial Clinical Trial Designs With Dr Ciolino","factorial-clinical-trial-designs-with-dr-ciolino","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Factorial_Clinical_Trial_Designs_With_Dr_Ciolino.mp3?dest-id=1862984",45960472,1147,"2025-08-07T15:00:00Z",{"_49":107,"_34":108,"_36":109,"_32":110,"_63":64,"_65":111,"_67":112,"_69":113,"_71":72,"_73":46,"_15":16},"ae6eb0dc-4f9e-4e86-85d0-8e7dedeff914","JAMA Guide to Statistics and Methods: Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis With Professor Brooks","jama-guide-to-statistics-and-methods-assessing-unexpected-circumstances-that-lead-to-modifications-in-clinical-trial-design-conduct-or-analysis-with-professor-brooks","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/JAMA_Guide_to_Statistics_and_Methods_Assessing_Unexpected_Circumstances_That_Lead_to_Modifications_in_Clinical_Trial_Design_Conduct_or_Analysis_With_Professor_Brooks.mp3?dest-id=1862984",40234587,1004,"2025-07-03T15:00:00Z",{"_49":115,"_34":116,"_36":117,"_32":118,"_63":64,"_65":119,"_67":120,"_69":121,"_71":72,"_73":46,"_15":16},"9754ae0f-2eef-43a7-821b-57f2c3099094","JAMA Guide to Statistics and Methods: Collider Bias With Dr Andersen","jama-guide-to-statistics-and-methods-collider-bias-with-dr-andersen","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/JAMA_Guide_to_Statistics_and_Methods_Collider_Bias_With_Dr_Andersen.mp3?dest-id=1862984",46704542,1166,"2025-06-05T15:00:00Z",{"_49":123,"_34":124,"_36":125,"_32":126,"_63":64,"_65":127,"_67":128,"_69":129,"_71":72,"_73":55,"_15":16},"f7a47516-28ad-4475-bb99-7a6459796f55","Nonparametric Statistical Analysis With Dr Lachin","nonparametric-statistical-analysis-with-dr-lachin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Nonparametric_Statistical_Analysis_With_Dr_Lachin.mp3?dest-id=1862984",28734234,716,"2025-04-03T15:00:00Z",{"_49":131,"_34":132,"_36":133,"_32":134,"_63":64,"_65":135,"_67":136,"_69":137,"_71":72,"_73":55,"_15":16},"b2a92152-94a0-4503-b086-811f23f672b2","The Use of Historical Controls in Clinical Trials, With Dr Althouse","the-use-of-historical-controls-in-clinical-trials-with-dr-althouse","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/The_Use_of_Historical_Controls_in_Clinical_Trials_With_Dr_Althouse.mp3?dest-id=1862984",49877349,1245,"2025-02-06T16:00:00Z",{"_49":139,"_34":140,"_36":141,"_32":142,"_63":64,"_65":143,"_67":144,"_69":145,"_71":72,"_73":55,"_15":16},"42ca7e35-8c95-4c92-a615-396fd2dd802d","Futility in Clinical Trials With Dr Wendelberger","futility-in-clinical-trials-with-dr-wendelberger","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Futility_in_Clinical_Trials_With_Dr_Wendelberger.mp3?dest-id=1862984",36467924,910,"2024-12-05T16:00:00Z",{"_49":147,"_34":148,"_36":149,"_32":150,"_63":64,"_65":151,"_67":152,"_69":153,"_71":72,"_73":55,"_15":16},"580ecd81-bbb8-4f07-86c5-18c3bdb1153b","Interim Analyses During Group Sequential Trials With Dr Meurer","interim-analyses-during-group-sequential-trials-with-dr-meurer","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Interim_Analyses_During_Group_Sequential_Trials_With_Dr_Meurer.mp3?dest-id=1862984",39052369,974,"2024-11-07T16:00:00Z",{"_49":155,"_34":156,"_36":157,"_32":158,"_63":64,"_65":159,"_67":160,"_69":161,"_71":72,"_73":55,"_15":16},"5c0cdfcb-45ac-45f1-b00d-ea43e0cc3b9a","Genome-Wide Association Studies With Dr Rotter","genome-wide-association-studies-with-dr-rotter","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Genome-Wide_Association_Studies_With_Dr_Rotter.mp3?dest-id=1862984",56321966,1406,"2024-09-05T15:00:00Z",{"_49":163,"_34":164,"_36":165,"_32":166,"_63":64,"_65":167,"_67":168,"_69":169,"_71":72,"_73":55,"_15":16},"5861237c-96fd-4b4c-95b0-6c70197af72f","Conditional Power: How Likely Is Trial Success?","conditional-power-how-likely-is-trial-success","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Conditional_Power_How_Likely_Is_Trial_Success.mp3?dest-id=1862984",39607273,988,"2024-08-01T16:45:00Z",{"_49":171,"_34":172,"_36":173,"_32":174,"_63":64,"_65":175,"_67":176,"_69":177,"_71":72,"_73":55,"_15":16},"8945d27e-5a32-4271-8f5d-1fd79496f7ad","Bayesian Hierarchical Models With Dr McGlothlin","bayesian-hierarchical-models-with-dr-mcglothlin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Bayesian_Hierarchical_Models_With_Dr_McGlothlin.mp3?dest-id=1862984",36349850,907,"2024-07-03T15:00:00Z",{"_49":179,"_34":180,"_36":181,"_32":182,"_63":64,"_65":183,"_67":184,"_69":185,"_71":72,"_73":55,"_15":16},"027d0fe4-9c22-41f0-b21a-4f3ca216243e","Sequential, Multiple Assignment, Randomized Trial Designs With Dr Kidwell","sequential-multiple-assignment-randomized-trial-designs-with-dr-kidwell","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Sequential_Multiple_Assignment_Randomized_Trial_Designs_With_Dr_Kidwell.mp3?dest-id=1862984",32359288,807,"2024-06-06T15:00:00Z",{"_49":187,"_34":188,"_36":189,"_32":190,"_63":64,"_65":191,"_67":192,"_69":193,"_71":72,"_73":55,"_15":16},"13d5ad3e-2225-4668-9f76-b45f47d8f89d","Target Trial Emulation for Causal Inference From Observational Data With Dr Hernán","target-trial-emulation-for-causal-inference-from-observational-data-with-dr-hernán","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Target_Trial_Emulation_for_Causal_Inference_From_Observational_Data_With_Dr_Hernn.mp3?dest-id=1862984",65868219,1645,"2024-05-02T15:00:00Z",{"_49":195,"_34":196,"_36":197,"_32":198,"_63":64,"_65":199,"_67":200,"_69":201,"_71":72,"_73":55,"_15":16},"7212e2ec-7143-4e83-b919-730863516f7a","On Deep Learning for Medical Image Analysis With Dr Carin","on-deep-learning-for-medical-image-analysis-with-dr-carin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/On_Deep_Learning_for_Medical_Image_Analysis_With_Dr_Carin.mp3?dest-id=1862984",55056404,1374,"2024-04-04T15:00:00Z",{"_49":203,"_34":204,"_36":205,"_32":206,"_63":64,"_65":207,"_67":208,"_69":209,"_71":72,"_73":55,"_15":16},"42a76818-3d20-4336-bba5-4bc065ed870e","Patient-Reported Outcome Measures in Clinical Research With Drs Weinfurt and Reeve","patient-reported-outcome-measures-in-clinical-research-with-drs-weinfurt-and-reeve","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Patient-Reported_Outcome_Measures_in_Clinical_Research_With_Drs_Weinfurt_and_Reeve.mp3?dest-id=1862984",53272353,1330,"2024-03-07T16:00:00Z",{"_49":211,"_34":212,"_36":213,"_32":214,"_63":64,"_65":215,"_67":216,"_69":217,"_71":72,"_73":55,"_15":16},"445454f3-49be-41fb-a2c6-7f907084cc6f","Immortal Time Bias in Observational Studies With Dr Kabir Yadav","immortal-time-bias-in-observational-studies-with-dr-kabir-yadav","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Immortal_Time_Bias_in_Observational_Studies_With_Dr_Kabir_Yadav.mp3?dest-id=1862984",36329367,906,"2024-01-04T16:00:00Z",{"_49":219,"_34":220,"_36":221,"_32":222,"_63":64,"_65":223,"_67":224,"_69":225,"_71":72,"_73":55,"_15":16},"a168523e-2d07-4859-bf07-b3a4f161812d","Adjustment for Baseline Characteristics in Randomized Clinical Trials","adjustment-for-baseline-characteristics-in-randomized-clinical-trials","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Adjustment_for_Baseline_Characteristics_in_Randomized_Clinical_Trials.mp3?dest-id=1862984",43866752,1095,"2023-12-07T16:00:00Z",{"_49":227,"_34":228,"_36":229,"_32":230,"_63":64,"_65":231,"_67":232,"_69":233,"_71":72,"_73":55,"_15":16},"83965a2c-7649-4d8d-bc67-e1e82be01e31","Odds Ratios—Current Best Practice and Use With Dr Norton","odds-ratioscurrent-best-practice-and-use-with-dr-norton","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Odds_Ratios_Current_Best_Practice_and_Use_With_Dr_Norton.mp3?dest-id=1862984",29625081,739,"2023-11-02T15:00:00Z",{"_49":235,"_34":236,"_36":237,"_32":238,"_63":64,"_65":239,"_67":240,"_69":241,"_71":72,"_73":55,"_15":16},"2e5832cf-973f-4b6c-bb6e-f44c0e93935b","Estimands, Estimators, and Estimates With Dr Little","estimands-estimators-and-estimates-with-dr-little","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Estimands_Estimators_and_Estimates_With_Dr_Little.mp3?dest-id=1862984",53106267,1326,"2023-08-03T15:00:00Z",{"_49":243,"_34":244,"_36":245,"_32":246,"_63":64,"_65":247,"_67":248,"_69":249,"_71":72,"_73":55,"_15":16},"bff642b3-e981-4991-9f23-b6392aca148f","Interpreting the Results of Intention-to-Treat, Per-Protocol, and As-Treated Analyses With Dr Smith","interpreting-the-results-of-intention-to-treat-per-protocol-and-as-treated-analyses-with-dr-smith","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Interpreting_the_Results_of_Intention-to-Treat_Per-Protocol_and_As-Treated_Analyses_With_Dr_Smith.mp3?dest-id=1862984",17769640,1105,"2023-05-04T15:00:00Z",{"_49":251,"_34":252,"_36":253,"_32":254,"_63":64,"_65":255,"_67":256,"_69":257,"_71":72,"_73":55,"_15":16},"ec84f874-0bfe-4933-ae64-efd81417e54e","Time-to-Event Analysis With Dr Tolles","time-to-event-analysis-with-dr-tolles","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Time-to-Event_Analysis_With_Dr_Tolles.mp3?dest-id=1862984",27248466,679,"2023-03-03T19:11:00Z",{"_49":259,"_34":260,"_36":261,"_32":262,"_63":64,"_65":263,"_67":264,"_69":265,"_71":72,"_73":55,"_15":16},"9e8dda0e-1833-4925-be74-f8313e94bb02","Adjusting for Nonadherence or Stopping Treatments With Drs Adler and Latimer","adjusting-for-nonadherence-or-stopping-treatments-with-drs-adler-and-latimer","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Adjusting_for_Nonadherence_or_Stopping_Treatments_With_Drs_Adler_and_Latimer.mp3?dest-id=1862984",17337199,1078,"2023-01-05T16:00:00Z",{"_49":267,"_34":268,"_36":269,"_32":270,"_63":64,"_65":271,"_67":272,"_69":273,"_71":72,"_73":55,"_15":16},"07a4692a-aeb0-4527-a70f-ee6665809e5b","Worst-Rank Score Methods—A Nonparametric Approach to Informatively Missing Data With Dr Lachin","worst-rank-score-methodsa-nonparametric-approach-to-informatively-missing-data-with-dr-lachin","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Worst-Rank_Score_Methods_A_Nonparametric_Approach_to_Informatively_Missing_Data_With_Dr_Lachin.mp3?dest-id=1862984",41007404,1026,"2022-11-03T15:00:00Z",{"_49":275,"_34":276,"_36":277,"_32":278,"_63":64,"_65":279,"_67":280,"_69":281,"_71":72,"_73":55,"_15":16},"540aded3-cd57-4ccf-a1ab-561c994e706b","Using Latent Class Analysis to Identify Hidden Clinical Phenotypes With Dr Heather G. Allore","using-latent-class-analysis-to-identify-hidden-clinical-phenotypes-with-dr-heather-g-allore","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Using_Latent_Class_Analysis_to_Identify_Hidden_Clinical_Phenotypes_With_Dr_Heather_G._Allore.mp3?dest-id=1862984",16954078,1054,"2022-09-01T15:00:00Z",{"_49":283,"_34":284,"_36":285,"_32":286,"_63":64,"_65":287,"_67":288,"_69":289,"_71":72,"_73":55,"_15":16},"c6b4fe40-7520-4c26-b84a-00e2a383abd7","Use of Run-in Periods in Randomized Trials With Dr Armitage","use-of-run-in-periods-in-randomized-trials-with-dr-armitage","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Use_of_Run-in_Periods_in_Randomized_Trials_With_Dr_Armitage.mp3?dest-id=1862984",46823597,1169,"2022-05-05T06:30:00Z",{"_49":291,"_34":292,"_36":293,"_32":294,"_63":64,"_65":295,"_67":296,"_69":297,"_71":72,"_73":55,"_15":16},"561d687d-6d9f-4fdb-bc0a-946fba476924","Regression Discontinuity Study Design to Estimate Observational Differences With Dr Maciejewski","regression-discontinuity-study-design-to-estimate-observational-differences-with-dr-maciejewski","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Regression_Discontinuity_Study_Design_to_Estimate_Observational_Differences_With_Dr_Maciejewski.mp3?dest-id=1862984",17278348,1074,"2022-04-07T15:00:00Z",{"_49":299,"_34":300,"_36":301,"_32":302,"_63":64,"_65":303,"_67":304,"_69":305,"_71":72,"_73":55,"_15":16},"c4a7fe83-449f-40ce-8ecc-ea660dfa4ac3","Case-Control Studies: Using \"Real-world\" Evidence to Assess Association, With Dr Irony","case-control-studies-using-real-world-evidence-to-assess-association-with-dr-irony","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Case-Control_Studies_Using_Real-world_Evidence_to_Assess_Association_With_Dr_Irony.mp3?dest-id=1862984",55579853,1387,"2021-12-02T16:00:00Z",{"_49":307,"_34":308,"_36":309,"_32":310,"_63":64,"_65":311,"_67":312,"_69":313,"_71":72,"_73":55,"_15":16},"913bd796-6eb4-4f23-ba79-becce2a0e1d2","Equipoise in Research—Integrating Ethics and Science in Human Research","equipoise-in-researchintegrating-ethics-and-science-in-human-research","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Equipoise_in_ResearchIntegrating_Ethics_and_Science_in_Human_Research.mp3?dest-id=1862984",52388749,1308,"2021-10-07T15:00:00Z",{"_49":315,"_34":316,"_36":317,"_32":318,"_63":64,"_65":319,"_67":320,"_69":321,"_71":72,"_73":55,"_15":16},"77061b99-7c8c-48d8-8d21-65565f14397b","Bayesian Analysis: Using Prior Information to Interpret the Results of Clinical Trials","bayesian-analysis-using-prior-information-to-interpret-the-results-of-clinical-trials","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Bayesian_Analysis__Using_Prior_Information_to_Interpret_the_Results_of_Clinical_Trials.mp3?dest-id=1862984",33067289,1651,"2021-09-02T15:00:00Z",{"_49":323,"_34":324,"_36":325,"_32":326,"_63":64,"_65":327,"_67":328,"_69":329,"_71":72,"_73":55,"_15":16},"bcb1b7c9-668c-44e1-a9c1-b25958c58cad","Cost-effectiveness Analysis for Clinicians","cost-effectiveness-analysis-for-clinicians","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Understanding_Cost-effectiveness_Analysis.mp3?dest-id=1862984",17716163,1101,"2021-08-05T15:00:00Z",{"_49":331,"_34":332,"_36":333,"_32":334,"_63":64,"_65":335,"_67":336,"_69":337,"_71":72,"_73":55,"_15":16},"7d973d53-3944-4a2a-a16c-c452df0e90ac","Multiple Comparison Procedures from the JAMA Guide to Statistics and Methods","multiple-comparison-procedures-from-the-jama-guide-to-statistics-and-methods","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Multiple_Comparison_Procedures_from_the_JAMA_Guide_to_Statistics_and_Methods.mp3?dest-id=1862984",21974198,1367,"2021-03-04T16:00:00Z",{"_49":339,"_34":340,"_36":341,"_32":342,"_63":64,"_65":343,"_67":344,"_69":345,"_71":72,"_73":55,"_15":16},"3b48e0bf-5036-4d41-87ad-99e8908bc3b3","Logistic Regression—What It Is and How to Use It in Clinical Research","logistic-regressionwhat-it-is-and-how-to-use-it-in-clinical-research","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Logistic_RegressionWhat_It_Is_and_How_to_Use_It_in_Clinical_Research.mp3?dest-id=1862984",39389377,1967,"2021-01-07T16:00:00Z",{"_49":347,"_34":348,"_36":349,"_32":350,"_63":64,"_65":351,"_67":352,"_69":353,"_71":72,"_73":55,"_15":16},"bcff3df6-0aec-4c92-941c-4f8e332a2e24","Randomization in Clinical Trials from the JAMA Guide to Statistics and Methods","randomization-in-clinical-trials-from-the-jama-guide-to-statistics-and-methods","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Randomization_in_Clinical_Trials_from_the_JAMA_Guide_to_Statistics_and_Methods.mp3?dest-id=1862984",22397812,1394,"2020-12-03T16:00:00Z",{"_49":355,"_34":356,"_36":357,"_32":358,"_63":64,"_65":359,"_67":360,"_69":361,"_71":72,"_73":55,"_15":16},"dfcb4210-c2ec-46b5-9720-db0fa5e7926c","The Stepped-Wedge Clinical Trial: Evaluation by Rolling Deployment","the-stepped-wedge-clinical-trial-evaluation-by-rolling-deployment","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/The_Stepped-Wedge_Clinical_Trial__Evaluation_by_Rolling_Deployment.mp3?dest-id=1862984",18483407,1087,"2020-09-03T15:00:00Z",{"_49":363,"_34":364,"_36":365,"_32":366,"_63":64,"_65":367,"_67":368,"_69":369,"_71":72,"_73":55,"_15":16},"6e982aec-a377-4264-8663-6d61001c85fc","Minimal Clinically Important Difference: Defining What Really Matters to Patients","minimal-clinically-important-difference-defining-what-really-matters-to-patients","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Pragmatic_TrialsPractical_Answers_to__Real-world__Questions.mp3?dest-id=1862984",12336339,703,"2020-08-06T15:00:00Z",{"_49":371,"_34":372,"_36":373,"_32":374,"_63":64,"_65":375,"_67":376,"_69":377,"_71":72,"_73":55,"_15":16},"5dcf3301-15c1-44e2-8a02-2fa07a14c69d","Sample Size Calculation for a Hypothesis Test With Dr Lynne Stokes","sample-size-calculation-for-a-hypothesis-test-with-dr-lynne-stokes","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Sample_Size_Calculation_for_a_Hypothesis_Test_with_Dr_Lynne_Stokes.mp3?dest-id=1862984",11838218,734,"2020-07-02T15:00:00Z",{"_49":379,"_34":380,"_36":381,"_32":382,"_63":64,"_65":383,"_67":384,"_69":385,"_71":72,"_73":55,"_15":16},"d3c706a9-4fe8-407d-9f75-baa736ab0f1a","Pragmatic Trials: Practical Answers to \"Real-world\" Questions With Harold C. Sox, MD","pragmatic-trials-practical-answers-to-real-world-questions-with-harold-c-sox-md","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Pragmatic_Trials__Practical_Answers_to__Real-world__Questions_With_Harold_C._Sox_MD.mp3?dest-id=1862984",20485983,1274,"2020-06-25T15:00:00Z",{"_49":387,"_34":388,"_36":389,"_32":390,"_63":64,"_65":391,"_67":392,"_69":393,"_71":72,"_73":55,"_15":16},"c97fde83-1aca-44f0-a060-e4425ff8606a","Cluster Randomized Trials: Evaluating Treatments Applied to Groups With William J. Meurer, MD","cluster-randomized-trials-evaluating-treatments-applied-to-groups-with-william-j-meurer-md","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Cluster_Randomized_Trials__Evaluating_Treatments_Applied_to_Groups_With_William_J._Meurer_MD.mp3?dest-id=1862984",22749004,1419,"2020-05-07T15:00:00Z",{"_49":395,"_34":396,"_36":397,"_32":398,"_63":64,"_65":399,"_67":400,"_69":401,"_71":72,"_73":55,"_15":16},"b3aed250-a38d-455b-b96b-013414be36b4","Noninferiority Trials: Is a New Treatment Almost as Effective as Another? with Dr Amy Kaji","noninferiority-trials-is-a-new-treatment-almost-as-effective-as-another-with-dr-amy-kaji","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/Noninferiority_Trials__Is_a_New_Treatment_Almost_as_Effective_as_Another__with_Dr_Amy_Kaji.mp3?dest-id=1862984",10545217,652,"2020-02-06T16:00:00Z",{"_49":403,"_34":404,"_36":405,"_32":406,"_63":64,"_65":407,"_67":408,"_69":409,"_71":72,"_73":55,"_15":16},"4c6d3a7e-e29a-4d73-94be-9da6adb5f4cc","JAMA Guide to Statistics and Methods","jama-guide-to-statistics-and-methods","https://traffic.libsyn.com/secure/jamaevidencejamaguidetostatisticsandmethods/JAMA_Guide_to_Statistics_and_Methods.mp3?dest-id=1862984",13270100,823,"2019-12-05T14:00:00Z","episodeFrequency","Monthly","estimatedNextEpisodeAt","2026-05-07T16:00:00Z","episodeCount",43,"hasSeasons","seasonCount","dataUpdateCount",1,"dataUpdatedAt","error","errorUpdateCount","errorUpdatedAt","fetchFailureCount","fetchFailureReason","fetchMeta","isInvalidated","status","success","fetchStatus","idle","queryKey",[434,435,16],"podcasts","detail","queryHash","[\"podcasts\",\"detail\",\"0d324d20-779a-0138-ede8-0acc26574db2\"]",{"_26":27,"_28":439,"_432":442,"_436":444},{"_30":440,"_418":419,"_420":441,"_421":-5,"_422":6,"_423":6,"_424":6,"_425":-5,"_426":-5,"_427":55,"_428":429,"_430":431},"

Natalie Exner Dean, PhD, Associate Professor, Rollins School of Public Health, Emory University, discusses Test-Negative Study Designs for Evaluating Vaccine Effectiveness with JAMA Statistical Editor Roger J. Lewis, MD, PhD.

Related Content:

Test-Negative Study Designs for Evaluating Vaccine Effectiveness

",1775301111311,[443,435,18],"episodeShowNotes","[\"episodeShowNotes\",\"detail\",\"9f51ee83-b790-4fec-b063-08ed03d97b43\"]","actionData","errors"]

Test-Negative Study Designs for Evaluating Vaccine Effectiveness With Dr Dean

Episode Description

Never lose your place, on any device